In conclusion, under the guidance of the UGT1A1 genotype, an increased irinotecan dose in combination with CRT significantly improved the clinical response rate with acceptable toxicities in Chinese patients with locally advanced rectal cancer. The gene discussed is UGT1A1; the disease is rectal cancer.